The largest holder of Iqvia stock is Harris Associates LP, with 12.2 million shares (7.40% of the company), worth about $3.18 billion as of September 25, 2026. The 10 largest holders together own 45.4%.
In Q2 2026, 1,133 institutional holdings reports listed shares worth $30.60 billion.
Insiders reported 31 transactions in the last two years: 5 sales worth $22.68 million and 1 purchase. The newest one on file is from April 23, 2026 (Danhakl John G, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through April 23, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Harris Associates LP | 12.2 million | 7.40% | $3.2B |
| Vanguard Capital Management LLC | 10.9 million | 6.63% | $2.8B |
| BlackRock Advisors LLC | 10.3 million | 6.28% | $2.7B |
| State Street Corporation | 7.5 million | 4.56% | $2.0B |
| Vanguard Portfolio Management LLC | 7.5 million | 4.56% | $2.0B |
| GIC Pte Ltd. (Investment Management) | 6.5 million | 3.97% | $1.7B |
| JPMorgan Investment Management, Inc. | 6.1 million | 3.73% | $1.6B |
| Artisan Partners Holdings LP | 4.7 million | 2.88% | $1.2B |
| Boston Partners Global Investors, Inc. | 4.5 million | 2.71% | $1.2B |
| Geode Capital Management LLC | 4.5 million | 2.71% | $1.2B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,133 | – | $30.6B |
| Q1 2026 | 1,116 | 157.0 million | $26.9B |
| Q4 2025 | 1,185 | 161.0 million | $36.4B |
| Q3 2025 | 1,057 | 162.0 million | $30.7B |
| Q2 2025 | 1,034 | 163.0 million | $25.7B |
| Q1 2025 | 1,038 | 155.0 million | $27.2B |
| Q4 2024 | 1,055 | 154.0 million | $30.3B |
| Q3 2024 | 1,111 | 160.0 million | $37.6B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Danhakl John G | Apr 23, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Goggins Colleen A | Apr 23, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Leonard John M | Apr 23, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Burt Carol J | Apr 23, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Cherofsky Keriann | Feb 6, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Patel Bhavik | Feb 6, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Grenfell Alistair | Feb 6, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Bruehlman Ronald E | Feb 6, 2026 | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Sherbet Eric M | Feb 6, 2026 | General Counsel | Stock Award(Grant) at price 0.00 per share. | – |
| Staub Walter. Richard Iii | Feb 6, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Bousbib Ari B | Feb 6, 2026 | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Bousbib Ari B | Dec 18, 2025 | Chief Executive Officer | Sale at price 222.43 per share. | $8.1M |
Newest 12 of 31 insider transactions in the last two years.
Harris Associates LP, with 7.40% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.63%) and BlackRock Advisors LLC (6.28%).
1,133 institutional holdings reports listed Iqvia shares in Q2 2026 worth $30.60 billion.
In the last two years insiders reported 5 sales and 1 purchase (31 transactions in all); the newest on file is from April 23, 2026.